healthcare
New Horizon leads $70m Series C for Arrail Dental
New Horizon Capital has led a $70 million Series C round of funding for Arrail Dental Clinic, a Beijing-based dental service provider.
TPG, Fosun raise offer to secure China healthcare take-private
A consortium comprising TPG Capital and Fosun Industrial has agreed to privatize NASDAQ-listed Chinese healthcare provider Chindex International in a deal worth $461 million, after raising its offer to head off competition from a rival financial bidder.
China's Hony eyes manufacturing, healthcare opportunities
China-focused PE firm Hony Capital is tracking investment opportunities in state-owned manufacturing and healthcare companies as the government seeks to further restructure its assets.
India's SIDBI invests in diabetes hospital
SIDBI Venture Capital has invested INR180 million ($3 million) in the India Kanungo Institute of Diabetes Specialities (KIDS) via its Samridhi Fund.
China online health forum secures $1m from Lightspeed
Lightspeed China Partners has committed $1 million to Kanchufang, a Chinese online healthcare information operator.
TPG, Fosun target Chindex gets better buyout offer
Chindex International has received a take-private offer from an unspecified financial bidder that values the Chinese healthcare provider at around $414 million, exceeding an earlier offer submitted by TPG Capital and Fosun Industrial alongside the CEO.
PE-backed iKang Healthcare jumps 8.6% on US debut
Shares in iKang Healthcare Group – the Chinese healthcare services provider whose backers include GIC Private, Goldman Sachs and NewQuest Asia – climbed 8.6% on their NASDAQ trading debut following a $153 million IPO.
Rabo Equity’s India nutrition play
Valued at around INR720 billion ($11.9 billion), India’s pharmaceutical market continues to be a popular destination with private equity investors, but the sector has seen better days. A recent report by PricewaterhouseCoopers shows a tightening regulatory...
China healthcare: Innovation issues
There is plenty of buzz about investment in Chinese healthcare but the pharmaceuticals segment has yet to fulfill its promise as an R&D hub. Should PE and VC investors be looking for different angles?
BVCF raises $200m for third China life sciences fund
BVCF, a China life sciences-focused PE firm, has reached a final close of $200 million on its third fund.
MSPEA makes another partial exit from Sihuan Pharma
Morgan Stanley Private Equity Asia (MSPEA) has made another partial exit from Hong Kong-listed Sihuan Pharmaceuticals, generating up to HK$1.12 billion ($145 million) through a block trade.
EQT scans I-Med opportunity
When EQT made its first move to acquire Australian radiology provider I-Med, the first challenge was to build trust with the company’s management. The business had already been through a number of financial investors’ hands and it had not been an...
KKR completes Panasonic Healthcare deal, eyes bolt-ons
KKR has completed the acquisition of an 80% stake in Panasonic Healthcare, its biggest buyout in Japan to date. According to a source familiar with the situation, operations unit KKR Capstone is already working with the company and a number of bolt-on...
Rabo Equity invests in Indian biotech firm
Rabo Equity Advisors' India Agribusiness Fund has invested INR750 million ($13 million) in Beloorbayir Biotech, a Bangalore-based drug developer.
China Aier Eye Hospital invests in Huatai Securities’ M&A fund
Shenzhen-listed Aier Eye Hospital Group plans to commit RMB100 million ($16 million) to an M&A fund managed by Huatai United Securities, an investment banking arm of Huatai Securities.
China health data start-up secures $2m angel round
China health data mobile app provider 37 Health has secured a RMB10 million ($2 million) seed funding round led by Broadhi Capital.
NewQuest, GIC set for partial exits from China’s iKang
NewQuest Capital Partners and GIC Private will each make partial exits from iKang Healthcare Group as the Chinese healthcare services provider looks to raise up to $175 million through a NASDAQ IPO.
EQT confirms acquisition of Australia's I-Med
EQT Partners has confirmed its acquisition of Australian radiology provider I-Med Network Radiology alongside Caisse de dépôt et placement du Québec of Canada and Singapore's GIC Private.
ChrysCapital invests $20m in India's Torrent Pharma - report
ChrysCapital is said to have acquired a stake in Ahmedabad-based drug company Torrent Pharmaceuticals for around INR1.2 billion ($19 million).
India’s Persistent backs hand hygiene wearables start-up
Persistent Venture Fund, a VC fund controlled by listed Indian software and technology company Persistent Systems, has invested in Hyginex, a US-based wearable technology manufacturer specializing in healthcare applications.
General Atlantic invests in India's CitiusTech
General Atlantic has invested in Indian healthcare technology services firm CitiusTech. Financial details were not disclosed but GA is understood to have paid around $110 million for a significant minority stake.
China Aier Eye Hospital invests in Qianhai M&A fund
Shenzhen-listed Aier Eye Hospital Group has launched an M&A fund with China Orient Asset Management with a view to bringing about consolidation in the ophthalmology industry.
China’s Hainan Haiyao to invest $20m in pharma-focused JV
China’s Hainan Haiyao, a Shenzhen-listed drug maker and distributor, plans to invest RMB122 million ($20 million) in a pharma-focused joint venture with several venture capital firms.
PE-backed China iKang Healthcare files for $150m US IPO
IKang Healthcare Group - the Chinese healthcare services provider whose backers include Singapore sovereign wealth fund GIC Private, Goldman Sachs and NewQuest Asia - is planning to raise up to $150 million in an initial public offering on NASDAQ.